The Gerresheimer Group expands its activities in the pharmaceutical
plastic business, with two strategically significant investments in
the USA and Europe. This week the company is almost simultaneously
opening a new research and development center for medical plastic
systems in the USA as well as a new production center for
pharmaceutical plastic packaging in Spain.
“Plastics are increasingly gaining in importance within our highly
specialized service portfolio for the international pharmaceutical
industry,” Gerresheimer AG CEO Dr. Axel Herberg says.
The new
technological center in Peachtree City (Georgia/USA) is opening up a
new dimension for the Group’s flourishing business with American
industrial clients from the pharmaceutical, diagnostics and medical
technology industry. As a full service provider for medical plastic
systems, Gerresheimer has upgraded the US location, which has until
recently been limited to manufacturing, to become a comprehensively
operating research, development and production center.
The newly opened
plant in Masalavés in Spain (region of Valencia) is also highly
significant with regard to the broad market of standardized
pharmaceutical system packaging made of plastics. The plant is deemed
to be the biggest production center of its kind in Southern Europe and
is a significant strategic base for Gerresheimer there as well as in
the Central European region. Pharmaceutical bottles and
multifunctional dosage and closure systems, for example for eye drops,
contact lens care products, nose sprays as well as tablets, are being
produced there.
All in all, the
company now possesses 15 locations in Europe, America and Asia in this
sector. Both segments of the plastics division are continuing to
attain above average growth rates. Accounting for a third of group
sales, plastics have already become the largest growth area within the
Gerresheimer Group.
For more
information, visit
www.gerresheimer.com.